?
z.B. 0-20
?
z.B. 0-15
?
z.B. 0-5
?
z.B. 0-3
Aktien Screener: Pharmazeutika
Filter & Suche
496 Ergebnisse (1 aktive Filter)
Die Kennzahlen-Filter werden aktiviert, sobald die vollständige Liste geladen ist.
Suchergebnisse
496 Unternehmen gefunden • Seite 14 von 20
? | ? | ? | ? | ? | ? | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 | Arbutus Biopharma Corp | 28.7 | Arzneimittel (Biotechnologie) | USA | 0.7 Mrd. USD | 4.33 | - | 3.64 | 2.56 | ▲ 15.29% | ▼ -12.07% | - | - | - | -237.88% | ▼ -4.30% | -192.08% | ▼ -11.49% | -281.45% | ▼ -28.09% | 4 / 9 | −39,33 | −253,4-fach | 14 / 100 | 6,5 / 100 | 0,28 |
 | Chengzhi Shareholding Co Ltd | 28.6 | Arzneimittel (Biotechnologie) | China | 0.9 Mrd. USD | 79.66 | - | 0.57 | 0.34 | ▲ 2.53% | - | - | - | - | -0.71% | ▼ -1.63% | 4.22% | ▼ -1.08% | 2.27% | ▼ -2.35% | 4 / 9 | 2,99 | 3-fach | 6 / 100 | −4,3 / 100 | −2,63 |
 | Roivant Sciences Ltd | 28.6 | Arzneimittel (Biotechnologie) | Vereinigtes Königreich - UK | 26.8 Mrd. USD | - | - | 3558.87 | 6.34 | ▼ -19.07% | ▼ -18.01% | - | - | - | -3629.19% | ▼ -159.23% | -15560.57% | ▼ -2800.50% | -9183.51% | ▼ -1604.23% | 2 / 9 | 16,68 | > 50-fach | 0 / 100 | 9,1 / 100 | - |
 | Iovance Biotherapeutics Inc | 28.4 | Arzneimittel (Biotechnologie) | USA | 6.7 Mrd. USD | - | - | 20.64 | 9.11 | - | - | - | - | - | -148.38% | - | -151.12% | - | -127.61% | - | 5 / 9 | −7,20 | - | 10 / 100 | −9,7 / 100 | −2,96 |
| ADICON Holdings Ltd | 28.4 | Arzneimittel (Biotechnologie) | China | 0.4 Mrd. USD | 148.24 | - | 1.04 | 1.59 | ▼ -0.77% | ▼ -42.13% | - | - | - | 0.70% | ▼ -2.97% | 3.81% | ▼ -3.16% | 4.45% | ▼ -2.36% | 5 / 9 | 2,04 | 4-fach | 20 / 100 | −4,4 / 100 | −2,59 |
 | Perrigo Company PLC | 28.4 | Arzneimittel (Pharmazeutisch) | Irland | 2.2 Mrd. USD | - | 12.62 | 0.53 | 0.88 | ▲ 0.79% | ▲ 54.37% | 7.29% | ▲ 3.86% | 22 Jahre | -33.51% | ▼ -6.45% | 8.07% | ▼ -0.29% | 3.41% | ▲ 0.75% | 5 / 9 | −0,38 | −1,7-fach | 18 / 100 | −19,5 / 100 | −3,74 |
| Green Cross Corp | 28.1 | Arzneimittel (Biotechnologie) | Südkorea | 1.1 Mrd. USD | - | 26.77 | 0.77 | 1.22 | ▲ 5.77% | - | 1.15% | - | - | -0.23% | ▼ -2.19% | 3.47% | ▼ -0.55% | -0.29% | ▼ -1.08% | 6 / 9 | 2,30 | 0-fach | 20 / 100 | −3,7 / 100 | −2,73 |
 | CG Oncology, Inc. Common stock | 28.1 | Arzneimittel (Biotechnologie) | USA | 5.7 Mrd. USD | - | - | 910.31 | 5.51 | - | - | - | - | - | -3985.02% | ▲ 310.49% | -4722.13% | ▼ -81.47% | -3279.21% | ▲ 238.74% | 4 / 9 | 23,38 | −42,1-fach | −0 / 100 | −3,6 / 100 | 2,50 |
| Aktis Oncology, Inc. Common stock | 28.1 | Arzneimittel (Biotechnologie) | USA | 0.9 Mrd. USD | - | - | 92.99 | 1.93 | ▲ 35.11% | ▲ 15.59% | - | - | - | -980.93% | ▲ 3.24% | -1149.52% | ▼ -182.52% | -1134.54% | ▲ 249.85% | 3 / 9 | 1,01 | −26,4-fach | 2 / 100 | 0,2 / 100 | −0,20 |
 | Immunitybio Inc | 28.0 | Arzneimittel (Biotechnologie) | USA | 9.3 Mrd. USD | - | - | 56.32 | -8.92 | ▲ 184.76% | ▲ 22.18% | - | - | - | -310.18% | ▲ 24440.35% | -226.00% | ▲ 21431.17% | -272.56% | ▲ 23590.01% | 4 / 9 | −24,62 | −2,5-fach | 22 / 100 | −9,3 / 100 | 4,30 |
 | Dianthus Therapeutics Inc. | 27.8 | Arzneimittel (Biotechnologie) | USA | 4.6 Mrd. USD | - | - | 2418.05 | 3.93 | - | - | - | - | - | -7973.33% | ▼ -1508.94% | -8739.34% | ▼ -1687.63% | -6349.36% | ▼ -526.13% | 3 / 9 | 14,36 | - | 0 / 100 | −6,3 / 100 | −4,59 |
 | Ideaya Biosciences Inc | 27.7 | Arzneimittel (Biotechnologie) | USA | 3.3 Mrd. USD | - | - | 14.00 | 2.73 | ▲ 62.11% | ▲ 28.65% | - | - | - | -51.99% | ▼ -357.72% | -72.84% | ▼ -433.42% | -33.59% | ▼ -306.31% | 4 / 9 | 13,17 | −22,3-fach | −9 / 100 | −3,8 / 100 | 13,72 |
 | Aclaris Therapeutics Inc | 27.5 | Arzneimittel (Pharmazeutisch) | USA | 0.6 Mrd. USD | - | - | 70.92 | 4.68 | ▲ 3.84% | ▲ 4.94% | - | - | - | -829.58% | ▲ 61.54% | -975.91% | ▲ 24.61% | -603.42% | ▲ 46.57% | 4 / 9 | −15,48 | - | 4 / 100 | −11,1 / 100 | 4,20 |
 | Insmed Inc | 27.5 | Arzneimittel (Biotechnologie) | USA | 24.4 Mrd. USD | - | - | 21.42 | 32.17 | ▲ 29.83% | ▲ 34.13% | - | - | - | -210.54% | ▼ -1.48% | -194.04% | ▼ -4.51% | -159.55% | ▲ 4.73% | 5 / 9 | −7,29 | −10,7-fach | 21 / 100 | −15,1 / 100 | −2,16 |
 | Editas Medicine Inc | 27.3 | Arzneimittel (Biotechnologie) | USA | 0.5 Mrd. USD | - | - | 9.64 | 4.30 | ▼ -14.89% | ▲ 7.91% | - | - | - | -395.01% | ▲ 96.23% | -245.15% | ▲ 139.10% | -409.30% | ▲ 76.89% | 4 / 9 | −29,69 | −64,8-fach | 22 / 100 | 2,8 / 100 | −5,52 |
 | Xenon Pharmaceuticals Inc | 27.3 | Arzneimittel (Biotechnologie) | Kanada | 3.5 Mrd. USD | - | - | 351.36 | 5.00 | ▲ 89.00% | ▲ 62.31% | - | - | - | -4612.13% | ▼ -928.92% | -4974.27% | ▼ -996.61% | -3732.23% | ▼ -820.87% | 2 / 9 | −1,50 | −83,2-fach | 1 / 100 | −6,8 / 100 | −2,04 |
| Chongqing Pharscin Pharmaceutical Co Ltd | 27.3 | Arzneimittel (Pharmazeutisch) | China | 0.8 Mrd. USD | 60.12 | - | 6.64 | 3.20 | ▼ -1.29% | ▼ -11.40% | 0.55% | - | - | 7.87% | ▼ -0.86% | 8.42% | ▼ -0.93% | 5.76% | ▲ 3.02% | 6 / 9 | 9,77 | > 50-fach | 24 / 100 | 0,1 / 100 | −3,19 |
 | Agios Pharm | 27.2 | Arzneimittel (Biotechnologie) | USA | 2.3 Mrd. USD | - | - | 23.14 | 2.22 | ▼ -23.27% | ▲ 4.75% | - | - | - | -764.01% | ▼ -774861.58% | -873.87% | ▲ 182752.68% | -698.33% | ▲ 199476.83% | 3 / 9 | 12,83 | - | 3 / 100 | −3,1 / 100 | −1,68 |
| Jinling Pharmaceutical Co Ltd | 26.9 | Arzneimittel (Pharmazeutisch) | China | 0.6 Mrd. USD | 82.30 | - | 1.15 | 0.97 | ▲ 5.01% | ▼ -3.71% | 1.68% | - | - | 1.69% | ▼ -0.79% | 1.13% | ▼ -1.53% | 0.51% | ▼ -0.78% | 7 / 9 | 8,25 | 27-fach | 13 / 100 | −2,4 / 100 | −1,98 |
| Beijing SL Pharmaceutical Co Ltd | 26.9 | Arzneimittel (Biotechnologie) | China | 0.8 Mrd. USD | - | - | 9.26 | 1.07 | ▼ -10.93% | - | 0.20% | ▼ -36.90% | - | -55.67% | ▼ -21.50% | -0.42% | ▼ -11.94% | 10.37% | ▼ -5.68% | 4 / 9 | 9,20 | > 50-fach | 6 / 100 | −10,0 / 100 | −3,63 |
 | Axsome Therapeutics Inc | 26.9 | Arzneimittel (Pharmazeutisch) | USA | 7.5 Mrd. USD | - | - | 9.68 | 90.24 | - | - | - | - | - | -28.69% | ▲ 319.92% | -26.51% | ▲ 306.15% | -14.70% | ▲ 263.26% | 5 / 9 | −5,75 | −35,2-fach | 86 / 100 | −13,0 / 100 | −2,65 |
| Cosmo Pharmaceuticals N.V | 26.7 | Arzneimittel (Pharmazeutisch) | Irland | 1.2 Mrd. USD | - | - | 10.47 | 1.90 | ▲ 11.45% | ▼ -14.40% | 3.54% | - | - | -3.46% | ▼ -4.05% | -10.00% | ▼ -2.58% | -15.12% | ▼ -0.95% | 3 / 9 | 7,50 | 18-fach | 8 / 100 | 1,3 / 100 | 0,13 |
 | Recursion Pharmaceuticals Inc | 26.7 | Arzneimittel (Biotechnologie) | USA | 2.6 Mrd. USD | - | - | 47.41 | 2.84 | ▲ 85.36% | ▲ 49.27% | - | - | - | -863.35% | ▲ 165.01% | -867.87% | ▲ 172.49% | -506.52% | ▲ 262.61% | 4 / 9 | −1,10 | −413,4-fach | −3 / 100 | −18,5 / 100 | −3,63 |
 | Bicycle Therapeutics Ltd | 26.7 | Arzneimittel (Biotechnologie) | Vereinigtes Königreich - UK | 0.3 Mrd. USD | - | - | 4.43 | 0.53 | ▲ 47.52% | ▲ 33.83% | - | - | - | -301.66% | ▲ 83.94% | -341.28% | ▲ 65.10% | -347.22% | ▼ -15.06% | 4 / 9 | 5,54 | −109,0-fach | 10 / 100 | 4,3 / 100 | −4,11 |
 | NewAmsterdam Pharma Company N.V. Ordinary Shares | 26.6 | Arzneimittel (Biotechnologie) | Niederlande | 2.5 Mrd. USD | - | - | 348.49 | 3.93 | - | - | - | - | - | -905.74% | - | -1002.90% | - | -657.82% | - | 3 / 9 | 8,38 | −90,5-fach | 3 / 100 | −7,3 / 100 | 1,09 |
